AANS Neurosurgeon | Volume 26, Number 3, 2017


Natural Molecule Could Improve Parkinson's

A natural molecule shows benefit in preliminary clinical trial for Parkinson’s Disease

According to many, the lack of dopamine in the brain is thought to be the cause of Parkinson’s disease. Current treatments for Parkinson’s include replacing dopamine within the brain and medications that are designed to slow the progression of the disease. In this study, researchers found that the natural molecule, n-acetylcysteine (NAC), with it’s strong antioxidant effects, could potentially benefit Parkinson’s disease management for patients. “This study reveals a potentially new avenue for managing Parkinson’s patients and shows that n-acetylcysteine may have a unique physiological effect that alters the disease process and enables dopamine neurons to recover some function,” said senior author on the paper Daniel Monti, MD, MBA, director of the Myrna Brind Center of Integrative Medicine and the Brind-Marcus Center of Integrative Medicine at Thomas Jefferson University. To read more, click here.


8th World Congress of Neuroendoscopy
Nov. 1-4, 2017; Cape Town, South Africa

3rd Annual Selected Topics in Craniomaxillofacial Surgery
Nov. 4, 2017 - Nov. 5, 2017; Boston, Mass.

Interactive Calendar

Comments are closed.